<PAGE>
As filed with the Securities and Exchange Commission on May 10, 1996
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12 (b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ADEZA BIOMEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 77-0054952
(State of incorporation or organization) (IRS Employer
Identification No.)
1240 ELKO DRIVE, SUNNYVALE, CA 94089
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
------------------- ------------------------------
None None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value
------------------------------
(Title of Class)
<PAGE>
Item 1. Description of Registrant's Securities to be Registered
-------------------------------------------------------
Incorporated by reference to the information set forth under the caption
"Description of Capital Stock" in the Company's Registrant's Registration
Statement on Form S-1 (SEC File No. 333-_____________) (the "Registration
Statement").
Item 2. Exhibits
--------
The following exhibits are filed as a part of this Registration
Statement:
1 Specimen certificate for Registrant's Common Stock (to be
supplied by amendment).
2.1 Certificate of Incorporation -- incorporated herein by
reference to Exhibit 3.1 of the Company's Registration
Statement.
2.2 Form of Amended and Restated Certificate of Incorporation to
be filed with the Delaware Secretary of State upon the
Company's reincorporation in Delaware -- incorporated herein
by reference to Exhibit 3.3 to the Registration Statement.
2.3 Bylaws -- incorporated herein by reference to Exhibit 3.2 to
the Company's Registration Statement.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Date: May 10, 1996 ADEZA BIOMEDICAL CORPORATION
By: /s/ Daniel O. Wilds
------------------------------------
Daniel O. Wilds, President
and Chief Executive Officer
-3-
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Sequentially
Exhibit No. Description Numbered Page
- ----------- ------------ -------------
<S> <C> <C>
1 Specimen certificate for Registrant's Common To be supplied by
Stock amendment
2.1 Certificate of Incorporation -- incorporated Incorporated by
herein by reference to Exhibit 3.1 of the reference
Company's Registration Statement
2.2 Form of Amended and Restated Certificate of Incorporated by
Incorporation to be filed with the Delaware reference
Secretary of State upon the Company's
reincorporation in Delaware -- incorporated
herein by reference to Exhibit 3.3 to the
Registration Statement.
2.3 Bylaws -- incorporated herein by reference Incorporated by
to Exhibit 3.2 to the Company's Registration reference
Statement.
</TABLE>
-4-
